Paper39107166
Myopathic manifestations across the adult lifespan of patients with malignant hyperthermia susceptibility: a narrative review.
Ibarra Moreno CA and 8 others. Br J Anaesth, 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Myopathic manifestations across the adult lifespan of patients with malignant hyperthermia susceptibility: a narrative review. Papers, record 39107166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39107166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Myopathic manifestations across the adult lifespan of patients with malignant hyperthermia susceptibility: a narrative review.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Malignant Hyperthermia | Major topic |
| Muscular Diseases | Major topic |
| Humans | |
| Adult | |
| Quality of Life |
Source PubMed
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1745285 | Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. | Muscle Nerve | 1991 | https://conductscience.org/library/papers/1745285 | PubMed |
| 2 | 25367069 | Statin-induced muscle toxicity and susceptibility to malignant hyperthermia and other muscle diseases: a population-based case-control study including 1st and 2nd degree relatives. | Eur J Clin Pharmacol | 2015 | https://conductscience.org/library/papers/25367069 | PubMed |
| 3 | 2697156 | [Management of a patient with malignant hyperthermia susceptibility during anesthesia and daily living]. | Ann Fr Anesth Reanim | 1989 | https://conductscience.org/library/papers/2697156 | PubMed |
| 4 | 26159759 | Mechanisms underlying enhancements in muscle force and power output during maximal cycle ergometer exercise induced by chronic β2-adrenergic stimulation in men. | J Appl Physiol (1985) | 2015 | https://conductscience.org/library/papers/26159759 | PubMed |
| 5 | 32054689 | Investigating the genetic susceptibility to exertional heat illness. | J Med Genet | 2020 | https://conductscience.org/library/papers/32054689 | PubMed |
| 6 | 30635368 | SR Ca2+ leak in skeletal muscle fibers acts as an intracellular signal to increase fatigue resistance. | J Gen Physiol | 2019 | https://conductscience.org/library/papers/30635368 | PubMed |
| 7 | 19348031 | Fixing the leak. | Nat Rev Drug Discov | 2009 | https://conductscience.org/library/papers/19348031 | PubMed |
| 8 | 28687594 | Reduced threshold for store overload-induced Ca2+ release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease. | Biochem J | 2017 | https://conductscience.org/library/papers/28687594 | PubMed |
| 9 | 32364497 | Intracellular calcium leak lowers glucose storage in human muscle, promoting hyperglycemia and diabetes. | Elife | 2020 | https://conductscience.org/library/papers/32364497 | PubMed |
| 10 | 15534757 | Pilot trial of salbutamol in central core and multi-minicore diseases. | Neuropediatrics | 2004 | https://conductscience.org/library/papers/15534757 | PubMed |
| 11 | 30579418 | Is malignant hyperthermia associated with hyperglycaemia? | Br J Anaesth | 2019 | https://conductscience.org/library/papers/30579418 | PubMed |
| 12 | 28902673 | Malignant Hyperthermia Susceptibility and Related Diseases. | Anesthesiology | 2018 | https://conductscience.org/library/papers/28902673 | PubMed |
| 13 | 37154182 | Muscle Ultrasound Abnormalities in Individuals with RYR1-Related Malignant Hyperthermia Susceptibility. | J Neuromuscul Dis | 2023 | https://conductscience.org/library/papers/37154182 | PubMed |
| 14 | 38318125 | Rycal S48168 (ARM210) for RYR1-related myopathies: a phase one, open-label, dose-escalation trial. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/38318125 | PubMed |
| 15 | 20010423 | Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms. | Anesthesiology | 2010 | https://conductscience.org/library/papers/20010423 | PubMed |
| 16 | 18394989 | RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. | Cell | 2008 | https://conductscience.org/library/papers/18394989 | PubMed |
| 17 | 23092431 | Ryanodine receptor patents. | Recent Pat Biotechnol | 2012 | https://conductscience.org/library/papers/23092431 | PubMed |
| 18 | 23628358 | Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis. | Neuromuscul Disord | 2013 | https://conductscience.org/library/papers/23628358 | PubMed |
| 19 | 29635721 | Phenotype and genotype of muscle ryanodine receptor rhabdomyolysis-myalgia syndrome. | Acta Neurol Scand | 2018 | https://conductscience.org/library/papers/29635721 | PubMed |
| 20 | 30579404 | Abnormal calcium signalling and the caffeine-halothane contracture test. | Br J Anaesth | 2019 | https://conductscience.org/library/papers/30579404 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42120542 | EMQN Best Practice Guidelines for Genetic Testing and Reporting in RYR1-related disorders. | Eur J Hum Genet | 2026 | https://conductscience.org/library/papers/42120542 | PubMed |
| 41389127 | Crosstalk between Ryanodine Receptor 2 Dysfunction and FK506-Binding Proteins in Pulmonary Hypertension. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/41389127 | PubMed |
| 40869992 | Genetic Panel Testing for Malignant Hyperthermia in Japan: Discovery of Novel Variants and Clinical Implications. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/40869992 | PubMed |
| 40835558 | Mitochondrial bioenergetics and intracellular calcium concentration in primary myotubes from mouse models of malignant hyperthermia. | Br J Anaesth | 2026 | https://conductscience.org/library/papers/40835558 | PubMed |
| 40597248 | Research hotspots and trends in malignant hyperthermia due to anesthesia from a global perspective: a bibliometric analysis from 1975 to 2024. | Orphanet J Rare Dis | 2025 | https://conductscience.org/library/papers/40597248 | PubMed |
| 40590017 | Malignant hyperthermia crisis during scoliosis surgery in a pediatric cerebral palsy patient: a case of early recognition and successful intervention. | Front Pediatr | 2025 | https://conductscience.org/library/papers/40590017 | PubMed |
| 39848431 | Skeletal muscle disorders as risk factors for type 2 diabetes. | Mol Cell Endocrinol | 2025 | https://conductscience.org/library/papers/39848431 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RYR1 | 6261 | PubTator's text mining | https://conductscience.org/library/genes/6261 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39107166
GET https://conductscience.org/api/papers/v1/39107166/references?page=2